V souladu s legislativou České republiky poskytuje Společnost služby pouze kvalifikovaným investorům!

Akoya Biosciences (AKYA) FINANCIAL RESULTS FOR SECOND QUARTER 2022.

Start-ups and IPO

09.08.2022

GAAP net loss per share for the second quarter of 2022 was -0.47 dollars.

Revenue was $17.9 million, up 37.0% from the same period last year.

Categories